We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for ...

OpenAI has met with the FDA to discuss using AI to speed up drug evaluations, part of the agency’s broader push to adopt AI ...

The government held a consultative meeting with private sector stakeholders Thursday to promote the use of artificial ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

Tech companies are focusing on AI products over research, say industry experts, who are sounding the alarm about safety.